Status:
NOT_YET_RECRUITING
A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042
Lead Sponsor:
Ahn-Gook Pharmaceuticals Co.,Ltd
Conditions:
Pharmacokinetics
Eligibility:
All Genders
19-65 years
Phase:
PHASE1
Brief Summary
The objective of this study is to evaluate the pharmacokinetic characteristics of AG2304 in healthy subjects.
Detailed Description
To evaluate the pharmacokinetic characteristics and safety profiles of AG2304 compared with coadministration AG23041 and AG23042 after a single oral dose administration in healthy Korean subjects unde...
Eligibility Criteria
Inclusion
- A healthy adults aged 19-65 years at the time of screening
- Subjects who are deemed eligible based on the screening tests
Exclusion
- Subjects who have taken the investigational drug within 6 months prior to the first dose
- Other exclusions have been applied
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06916169
Start Date
August 1 2025
End Date
September 1 2025
Last Update
April 8 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.